CrowdStrike has pulled back sharply from its post-earnings peak, giving up 7% on September 1 to close at $215.07 — a week that started with euphoria and ended with sellers reasserting themselves, even as the stock remains 16% higher than where it stood seven days ago.
The reversal from $231 is the week's most interesting tension. After the 23% earnings gap documented in the prior note, short sellers have begun rebuilding — cautiously. Short interest edged up 2.1% on the day to 24.2 million shares, or 9.66% of the free float. That is still well below the mid-July peak above 28 million shares, and the weekly picture remains constructive for longs: SI is down nearly 7% on the week and 10% over the past month. The borrow market continues to offer zero friction. Availability is effectively unconstrained — over a billion shares available, cost to borrow at just 0.33%. There is no squeeze dynamic and no sign that the post-earnings short rebuild is anything more than opportunistic. Options positioning corroborates that reading: the put/call ratio is running at 0.95, almost exactly in line with its 20-day average and more than half a standard deviation below it. The defensive hedging that characterised the pre-earnings setup has not returned. Positioning looks calm rather than charged.
The Street is firmly onside following the print. Almost every analyst who updated over the past week raised their target. Truist lifted to $300 from $245. Citigroup moved to $260, Mizuho to $250, Jefferies to $240, and Palo Alto-focused BMO Capital jumped to $235 from $186 — a move that reflects genuine re-rating, not a routine trim. The consensus target now stands at $230.32, sitting above the current price of $215 and implying roughly 7% upside from here. The bull case centres on the Falcon platform's expanding module attach rates, the $10 billion ARR target, and what management is framing as a structural AI security advantage. Bears acknowledge the growth but flag valuation — the stock trades at 148 times trailing earnings and 105 times EV/EBITDA, multiples that leave almost no room for execution missteps. The EPS forward momentum score ranks in the 95th percentile of the universe, which squares with the beat-and-raise pattern, but the ORTEX short score of 33.4 has been declining all week from 35.4 a week ago — a signal that the aggregate short-side pressure on the name is easing, not building.
CEO George Kurtz sold just over 7,000 shares on August 28, aggregate value roughly $624,000, entirely under a pre-arranged 10b5-1 plan. The full 90-day net insider figure is -50,500 shares worth approximately $10.2 million. That sounds large in absolute terms, but the 10b5-1 designation matters: these are scheduled sales, not discretionary conviction signals. The context also matters — Kurtz was selling into the earnings rally, not ahead of a guidance cut.
The day-one giveback sits in a familiar pattern for CRWD. The August 26 earnings session saw a 23% jump. The next session produced a sharp mean-reversion, with the stock losing 7% while peers also retreated: PANW fell 5.2%, FTNT dropped 5.3%, and TENB declined 7%. The sector-wide pressure on September 1 makes it harder to read CRWD's pullback as stock-specific. SentinelOne and Rubrik both underperformed CRWD on the day, though RBRK is the only peer in the group that is still negative on the week.
What to watch next is whether the September 1 selloff attracts fresh short rebuilding or proves to be a post-earnings digestion that leaves the stock consolidating in the $210–$230 range ahead of the next scheduled earnings on November 24.
See the live data behind this article on ORTEX.
Open CRWD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
